Antiverse 2.png

Antiverse

Drug Discovery

Membership category
Emerging Y3

34th Cardiff Court Road, Cardiff, CF24 3SD, United Kingdom

Antiverse at a glance

Antiverse is accelerating the development of antibody biotherapeutics and diagnostics and revolutionising the detection and treatment of complex diseases, including cancer, heart and lung diseases.

About Antiverse

Antiverse is accelerating the development of antibody biotherapeutics and diagnostics and revolutionising the detection and treatment of complex diseases, including cancer, heart and lung diseases. Antiverse uses state-of-the-art machine learning to rapidly identify diverse and rare antibodies in silico by analysing NGS data from naïve and immune repertoires. The result is a 10 times higher chance of finding effective and developable antibodies. The Antiverse AI-augmented drug discovery solution is already in use by big pharma and is now being rolled out to a wider audience. Recognized as one of the most promising biotech startups in the UK, Antiverse is looking for partnerships to scale its impact.

Therapeutic area(s)

Articles Antiverse has contributed to